O'donnell Carol A

O'donnell Carol A is listed in filings as Director at Apimeds Pharmaceuticals US, Inc. This profile follows SEC Form 4 activity through Nov 13, 2025, including 4 public disclosures. Recent filings connect the profile to Apimeds Pharmaceuticals US, Inc (APUS) and Sono-Tek Corporation (SOTK). The current snapshot covers public activity from Aug 23, 2024 to Nov 13, 2025. Reported amounts are shown as $26.7K to $22.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.